1. OPUS at UTS

Browsing byAuthorChoi, JP

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 4 to 11 of 11< previous 
Issue DateTitleAuthor(s)
2020-01Generation of Cerebral Cavernous Malformation in Neonatal Mouse Models Using Inducible Cre-LoxP Strategy.Choi, JP; Zheng, X
2017-09-04Induction and Micro-CT Imaging of Cerebral Cavernous Malformations in Mouse Model.Choi, JP; Yang, X; Foley, M; Wang, X; Zheng, X
2019-11-01Low fluid shear stress conditions contribute to activation of cerebral cavernous malformation signalling pathwaysLi, J; Zhao, Y; Coleman, P; Chen, J; Ting, KK; Choi, JP; Zheng, X; Vadas, MA; Gamble, JR
2016Micro-CT Imaging Reveals Mekk3 Heterozygosity Prevents Cerebral Cavernous Malformations in Ccm2-Deficient Mice.Choi, JP; Foley, M; Zhou, Z; Wong, W-Y; Gokoolparsadh, N; Arthur, JSC; Li, DY; Zheng, X
2016Micro-CT Imaging Reveals Mekk3 Heterozygosity Prevents Cerebral Cavernous Malformations in Ccm2-Deficient Mice.Choi, JP; Foley, M; Zhou, Z; Wong, W-Y; Gokoolparsadh, N; Arthur, JSC; Li, DY; Zheng, X
2018-11Ponatinib (AP24534) inhibits MEKK3-KLF signaling and prevents formation and progression of cerebral cavernous malformations.Choi, JP; Wang, R; Yang, X; Wang, X; Wang, L; Ting, KK; Foley, M; Cogger, V; Yang, Z; Liu, F; Han, Z; Liu, R; Baell, J; Zheng, X
2024-05Targeting PKM2 signaling cascade with salvianic acid A normalizes tumor blood vessels to facilitate chemotherapeutic drug delivery.Qian, C; Zhou, Y; Zhang, T; Dong, G; Song, M; Tang, Y; Wei, Z; Yu, S; Shen, Q; Chen, W; Choi, JP; Yan, J; Zhong, C; Wan, L; Li, J; Wang, A; Lu, Y; Zhao, Y
2020The role of microbiome and NLRP3 inflammasome in the gut and the lungDonovan, C; Liu, G; Shen, S; Marshall, J; Kim, R; Alamao, CA; Budden, KF; Choi, JP; Kohonen-Corish, M; El-Omar, EM; Yang, IA; Hansbro, P
Showing results 4 to 11 of 11< previous